NCT07173764

Brief Summary

Syphilis is an infection which affects about 1 in 25 pregnant women in Uganda. If the infection is not diagnosed and treated this can be a risk to the mother and unborn baby's health. This study aims to see whether a new test for syphilis infection in mothers and babies which can give a result in 10 minutes is as good as the standard tests that are done in the laboratory and take hours or days to provide results.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2025

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 8, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

3 months

First QC Date

September 8, 2025

Last Update Submit

September 8, 2025

Conditions

Keywords

syphilispoint of care test

Outcome Measures

Primary Outcomes (1)

  • Primary outcomes

    Correlation of binary non-treponemal IgM and IgG results for the Chembio DPP Syphilis TnT with RPR positivity. Correlation of binary treponemal IgM and IgG results for the Chembio DPP Syphilis TnT with Treponemal Antibody (TPAB) positivity. Correlation of binary IgA and IgM results for the Chembio DPP Syphilis CS and Chembio DPP Syphilis TnT to the RPR results in mother and baby to confirm the diagnosis of congenital syphilis in the neonate.

    At enrolment

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Mothers delivering at Kawempe National Referral Hospital with a positive syphilis rapid diagnostic test during their current pregnancy.

You may qualify if:

  • Mothers delivering at Kawempe National Referral Hospital with a positive syphilis rapid diagnostic test during their current pregnancy.

You may not qualify if:

  • Mothers who are unable to give written informed consent.
  • Mothers with evidence of neurological symptoms compatible with neurological syphilis.
  • Mothers who are aged less than 14 years. Emancipated and mature minors are allowed to consent for research per Ugandan law.11
  • Mothers, who in the view of the study team, are unable to adhere to required study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kawempe National Referral Hospital

Kampala, Uganda

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum

MeSH Terms

Conditions

SyphilisSyphilis, Congenital

Condition Hierarchy (Ancestors)

Treponemal InfectionsSpirochaetales InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSexually Transmitted Diseases, BacterialSexually Transmitted DiseasesCommunicable DiseasesGenital DiseasesUrogenital DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2025

First Posted

September 15, 2025

Study Start

September 1, 2025

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

September 15, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations